Origin of restenosis after drug-eluting stent implantation in hyperglycemia is inflammatory cells and thrombus

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 7, 2011, Pages 604-615

  Kwon, Jin Sook ^a   Kim, Yong Sook ^a   Cho, Ae Shin ^a   Kim, Jeong Sook ^a   Jeong, Seo Yeon ^a   Hong, Moon Hwa ^a   Jeong, Myung Ho ^a   Ahn, Youngkeun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Drug eluting stents; Restenosis; Type 1 diabetes mellitus

Indexed keywords

FIBRIN; HYALURONIC ACID; PACLITAXEL; RAPAMYCIN; STEM CELL FACTOR; STREPTOZOCIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG ELUTING STENT; ENDOTHELIUM CELL; FIBRIN DEPOSITION; HYPERGLYCEMIA; HYPERPLASIA; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MORPHOMETRICS; NEOINTIMAL HYPERPLASIA; NONHUMAN; PROTEIN EXPRESSION; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; THROMBUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA; BODY WEIGHT; CORONARY RESTENOSIS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; FIBRIN; HUMANS; HYALURONIC ACID; HYPERGLYCEMIA; INFLAMMATION; MALE; PACLITAXEL; RATS; RATS, SPRAGUE-DAWLEY; SIROLIMUS; THROMBOSIS;

EID: 79960855782     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.6965     Document Type: Article

References (36)

1. Ruderman NB, Haudenschild C: Diabetes as an atherogenic factor. Prog Cardiovasc Dis, 1984; 26: 373-412
2. Laing SP, Swerdlow AJ, Carpenter LM, Slater SD, Burden AC, Botha JL, Morris AD, Waugh NR, Gatling W, Gale EA, Patterson CC, Qiao Z, Keen H: Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke, 2003; 34: 418-421
3. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC: Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia, 2003; 46: 760-765
4. Alderman EL, Andrews K, Bost J, Bourassa M, Chaitman BR, Detre K, Faxon DP, Follmann D, Frye RL, Hlatky M, Jones RH, Kelsey SF, Rogers WJ, Rosen AD, Schaff H, Mary Ann Sellers MA, Sopko G, Tyrrell KS, Williams DO: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med, 1996; 335: 217-225
5. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, Schuler G, Mohr FW, Lindeboom W, Sousa AG, Sousa JE, van Hout B, Hugenholtz PG, Unger F, Serruys PW: Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation, 2001; 104: 533-538
6. Abdel-Wahab M, Khattab AA, Toelg R, Geist V, Liska B, Richardt G: Plaque characteristics of nonobstructive coronary lesions in diabetic patients: an intravascular ultrasound virtual histology analysis. J Cardiovasc Med (Hagerstown), 2010; 11: 345-351
7. Ogita M, Funayama H, Nakamura T, Sakakura K, Sugawara Y, Kubo N, Ako J, Ishikawa SE, Momomura S: Plaque characterization of non-culprit lesions by virtual histology intravascular ultrasound in diabetic patients: impact of renal function. J Cardiol, 2009; 54: 59-65
8. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E: Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA, 2005; 293: 2126-2130
9. Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, Deme M, Stoll HP: Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation, 2006; 113: 1434-1441
10. Virmani R, Farb A, Kolodgie FD: Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences. Herz, 2002; 27: 1-6
11. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, Escaned J, Banuelos C, Fernandez-Ortiz A, Macaya C: Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol, 2005; 45: 954-959
12. McMahon AC, Zreiqat H, Lowe HC: Carotid artery stenting in the Zucker rat: a novel, potentially 'diabetes specific' model of in-stent restenosis. Diab Vasc Dis Res, 2008; 5: 145-146
13. Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C: Vascular neointimal formation and signaling pathway activation in response to stent injury in insulinresistant and diabetic animals. Circ Res, 2005; 97: 725-733
14. Zhang Q, Lu L, Pu L, Zhang R, Shen J, Zhu Z, Hu J, Yang Z, Chen Q, Shen W: Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine. Cardiovasc Diabetol, 2007; 6: 16
15. Faries PL, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, King GL, Logerfo FW: Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg, 2001; 33: 601-607
16. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005; 353: 2643-2653
17. Grant PJ: Diabetes mellitus as a prothrombotic condition. J Intern Med, 2007; 262: 157-172
18. Khechai F, Ollivier V, Bridey F, Amar M, Hakim J, de Prost D: Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler Thromb Vasc Biol, 1997; 17: 2885-2890
19. Zheng Y, Collins SL, Lutz MA, Allen AN, Kole TP, Zarek PE, Powell JD: A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J Immunol, 2007; 178: 2163-2170
20. Kotowicz K, Dixon GL, Klein NJ, Peters MJ, Callard RE: Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology, 2000; 100: 441-448
21. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Bonadonna RC: Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation, 2002; 105: 576-582
22. Campia U, Sullivan G, Bryant MB, Waclawiw MA, Quon MJ, Panza JA: Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile. Am J Physiol Heart Circ Physiol, 2004; 286: H76-82
23. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA: Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res, 2002; 90: 107-111
24. Martinet W, Verheye S, De Meyer GR: Everolimusinduced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy, 2007; 3: 241-244
25. Verheye S, Martinet W, Kockx MM, Knaapen MW, Salu K, Timmermans JP, Ellis JT, Kilpatrick DL, De Meyer GR: Selective clearance of macrophages in atherosclerotic plaques by autophagy. J Am Coll Cardiol, 2007; 49: 706-715
26. Cipolletta C, Ryan KE, Hanna EV, Trimble ER: Activation of peripheral blood CD14 monocytes occurs in diabetes. Diabetes, 2005; 54: 2779-2786
27. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemiaand cytokine-induced mobilization of bone marrowderived endothelial progenitor cells for neovascularization. Nat Med, 1999; 5: 434-438
28. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J, 1999; 18: 3964-3972
29. Segal MS, Bihorac A, Koc M: Circulating endothelial cells: tea leaves for renal disease. Am J Physiol Renal Physiol, 2002; 283: F11-19
30. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C: Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem, 1994; 42: 1417-1425
31. McDonald TO, Gerrity RG, Jen C, Chen HJ, Wark K, Wight TN, Chait A, O'Brien KD: Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis. J Histochem Cytochem, 2007; 55: 1149-1157
32. Heickendorff L, Ledet T, Rasmussen LM: Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia, 1994; 37: 286-292
33. Jarvelainen H, Ronnemaa T, Lehtonen A: Effect of sera from male type I (insulin-dependent) diabetics on human aortic smooth muscle cells in culture. Acta Endocrinol (Copenh), 1987; 114: 362-370
34. Jarvelainen H, Ronnemaa T, Viikari J: Effect of sera from male type 2 (non-insulin-dependent) diabetics on human aortic smooth muscle cells in culture. Med Biol, 1986; 64: 361-366
35. Wang A, Hascall VC: Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem, 2004; 279: 10279-10285
36. Levesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B: Localization and solubilization of hyaluronan and of the hyaluronanbinding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis, 1994; 105: 51-62